|
More than 476,000 babies were born prematurely
in the United States in 2001. Adeza Biomedical’s
challenge is to educate women, healthcare professionals,
hospitals and payors on the benefits of testing for
the risk of a failed In Vitro Fertilization and establishing
the risks of a premature birth.
With a direct U.S. sales force and representation in over
20 countries, Adeza Biomedical is striving to make a difference;
you can help by learning more about the risks of infertility
and premature delivery by contacting Adeza Biomedical.
|
